SCHEMBL30851646

SCHEMBL30851646

ClCc1ncccc1C1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.44
CXCR4 P61073 1/20 0.38
HTR1A P08908 9/20 0.37
SLC6A2 P23975 8/20 0.37
SLC6A4 P31645 8/20 0.37
SLC6A3 Q01959 4/20 0.37
CYP1A2 P05177 1/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
CYP2C19 P33261 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
THPO P40225 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NISCH Q9Y2I1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12059248 0.82 PDK2 (0.42) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL21942819 0.82 ALDH1A1 (0.52) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL17778193 0.82 PDK2 (0.42) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL29586612 0.82 PDK2 (0.42) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL30852252 0.82 ALDH1A1 (0.52) PDK2CXCR4HTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL4799073 0.81 PDK2 (0.41) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL15677609 0.79 PDK2 (0.41) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL24485234 0.78 HTR1A (0.40) PDK2HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL13310539 0.78 SSTR4 (0.40) PDK2CXCR4HTR1ASLC6A2SLC6A4
SCHEMBL27936549 0.78 PDK2 (0.43) PDK2CXCR4HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed